He has served as interim CEO since June, according to an Aug. 10 news release.
“Since creating Aziyo in 2015, Randy and I have worked together to build a company where regenerative medicine is used to its full potential,” Aziyo co-founder Kevin Rakin said in the release. “Randy is a visionary leader with a track record of creating significant shareholder value in regenerative medicine.”
Aziyo Biologics focuses on regenerative medicine for orthopedics, cardiology and reconstructive surgery. One of its products, the ViBone moldable cell bone matrix, debuted in spine surgery in January 2021.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
